Author:
Leyland-Jones B,Grieshaber C K
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Arbuck, SG (1996) Workshop on phase I study design. Ann Oncol 7: 567–573.
2. Collins, JM, Zaharko, DS, Dedrick, RL & Chabner, BA (1986) Potential roles for preclinical pharmacology in phase I clinical trials. Cancer Treat Rep 70: 73–80.
3. Collins, JM, Grieshaber, CK & Chabner, BA (1990) Pharmacologically guided phase I clinical trials based upon preclinical drug development. J Natl Cancer Inst 82: 1321–1326.
4. DeGeorge, JJ, Ahn, C-H, Andrews, PA, Brower, ME, Giorgio, DW, Goheer, ME, Lee-Ham, DY, McGuinn, WD, Schmidt, W, Sun, CJ & Tripathi, SC (1998) Regulatory considerations for preclinical development of anticancer drugs. Cancer Chemother Pharmacol 41: 173–185.
5. Dent, SF & Eisenhauer, EA (1996) Phase I trial design: are new methodologies being put into practice?. Ann Oncol 7: 561–566.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献